loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

List of All Manufacturers & Suppliers for 22074 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 LANREOTIDE ACETATE (3)

filter

01 IPSEN PHARMA (3)

filter

01 SOLUTION;SUBCUTANEOUS (3)

filter

01 EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML) (1)

02 EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML) (1)

03 EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML) (1)

filter

01 USA (3)

URL Supplier Web Content
SOLUTION;SUBCUTANEOUS
EQ 60MG BASE/0.2ML (EQ...
SOMATULINE DEPOT
USA
22074
2007-08-30
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SOLUTION;SUBCUTANEOUS
EQ 90MG BASE/0.3ML (EQ...
SOMATULINE DEPOT
USA
22074
2007-08-30
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SOLUTION;SUBCUTANEOUS
EQ 120MG BASE/0.5ML (E...
SOMATULINE DEPOT
USA
22074
2007-08-30
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 22074

Looking for CTD TGA MCC DOSSIER APPLICATION 22074 3

19

Ipsen, based in France, is a pharmaceutical company.

One of their notable products is LANREOTIDE ACETATE, with a corresponding application number 22074 and regulatory information .

proudly manufactured in the

approval since 2007-08-30

Ipsen's SOMATULINE DEPOT SOLUTION;SUBCUTANEOUS, medication with EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML) of LANREOTIDE ACETATE.

18

Ipsen, based in France, is a pharmaceutical company.

One of their notable products is LANREOTIDE ACETATE, with a corresponding application number 22074 and regulatory information .

proudly manufactured in the

approval since 2007-08-30

Ipsen's SOMATULINE DEPOT SOLUTION;SUBCUTANEOUS, medication with EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML) of LANREOTIDE ACETATE.

17

Ipsen, based in France, is a pharmaceutical company.

One of their notable products is LANREOTIDE ACETATE, with a corresponding application number 22074 and regulatory information .

proudly manufactured in the

approval since 2007-08-30

Ipsen's SOMATULINE DEPOT SOLUTION;SUBCUTANEOUS, medication with EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML) of LANREOTIDE ACETATE.

Post Enquiry
POST ENQUIRY